Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study - Archive ouverte HAL Access content directly
Journal Articles Clinical and Experimental Immunology Year : 2015

Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study

(1) , (1) , (2, 3, 4, 5) , (1) , (1) , (1) , (1) , (1) , (1) , (6, 4, 5, 7) , (1)
1
2
3
4
5
6
7

Abstract

Our objective was to evaluate the contribution of monitoring B cell subset depletion after rituximab in patients with rheumatoid arthritis (RA) in order to guide reintroduction to forestall relapse. This prospective, monocentre study included all RA patients receiving two 1-g rituximab infusions at a 15-day interval. The patients were followed clinically and biologically every 2 months until rituximab reintroduction. The physician was blinded to lymphocyte-typing results to diagnose relapse and, hence, retreatment. Among the 39 patients included between March 2010 and December 2011 and followed until April 2013, seven received two rituximab cycles, yielding a total of 46 cycles for analysis. After the two rituximab cycles, the total number of CD19+ B cells decreased significantly (0·155 versus 0·0002 G/l, P < 0·0001), with complete depletions in all patients of CD19+ CD38++CD24++ (transitional) (P < 0·0001) and CD19+ CD27+ (memory) B lymphocytes. A significant majority of patients relapsed within the 4 months following repopulation of total B (P = 0·036), B transitional (P = 0·007) and B memory (P = 0·01) lymphocytes. CD19+ B lymphocyte repopulation preceded clinical RA relapse and enabled its prediction 4 months in advance. Hence, monitoring of CD19+ B lymphocytes could serve as a tool to predict those relapses

Dates and versions

hal-02372200 , version 1 (20-11-2019)

Identifiers

Cite

A.-P. Trouvin, S. Jacquot, S. Grigioni, E. Curis, I. Dedreux, et al.. Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study. Clinical and Experimental Immunology, 2015, 180 (1), pp.11-18. ⟨10.1111/cei.12481⟩. ⟨hal-02372200⟩
25 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More